Amersham Sues PerkinElmer Over Drug Technology Patents
Amersham Biosciences and its parent, U.K.-based Amersham PLC, have filed a lawsuit in the U.S. District Court in Newark, NJ, against PerkinElmer Inc., alleging that PerkinElmer infringed on two of Amersham's...To view the full article, register now.
Already a subscriber? Click here to view full article